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PHARMACODYNAMICS AND 
DRUG ACTION 
Relationship of electroencephalographic 
and cardiovascular changes to plasma 
nicotine levels in tobacco smokers 
Objective: The effects of smoking one tobacco or placebo cigarette on the mean change in voltage of the 
electroencephalogram (EEG), arterial blood pressure, heart, and eye blink rates were correlated with the 
increase in plasma nicotine, exhaled carbon monoxide, and carboxyhemoglobin levels. 
Methodr: Twenty nonsmokers (age range, 19 to 42 years; mean age 2 SE, 27.0 2 1.9 years) and 65 
regular tobacco smokers (age range, 20 to 48 years; mean age + SE, 27.7 2 0.8 years) were studied 
about 10 to 12 hours after overnight tobacco deprivation and immediately after inhaling air through a 
straw or after smoking one of their own brands of cigarettes, respectively. 
Results: An increase of at least 10 nglml plasma nicotine was needed to obtain a statistically significant 
decrease in alpha, and an increase in beta EEG activity. An increase of at least 15 ng/ml plasma nicotine 
was needed to obtain a statistically significant decrease in delta EEG activity. The mean dominant alpha 
frequency, heart rate, systolic and diastolic blood pressure, exhaled carbon monoxide, and carboxyhemo- 
globin levels increased significantly with increasing plasma nicotine concentrations. 
Conclusions: Measurement of plasma nicotine levels is especially important to quantify the relationship 
between tobacco smoking, mean EEG activity, and cardiovascular changes. Nicotine plasma concentra- 
tions greater than 10 pglrnl produce consistent and statistically significant changes in brain wave activ- 
ity. Smaller increments in plasma nicotine produce less consistent EEG changes. (CLIN P-COL THER 
1994;55:370-7.) 
Chitoshi Kadoya, MD, Edward F. Domino, MS, MD, and Shigeaki Matsuoka, MD 
Ann Arbm, Mich., and Kitakyushu, Japan 
There have been many reports on the qualitative bacco smoking decreases delta (1 to 4 Hz) and theta 
and quantitative electroencephalographic (EEG) ef- (4.5 to 7.5 Hz) activity, increases the dominant alpha 
fects of tobacco smoking in humans. In general, to- (8-12 Hz) frequency, and increases activity in the 
beta, (12.5 to 17.5 Hz) and beta, (18 to 30 Hz) 
bands.'-l5 To date, there has been no study in which 
plasma levels of nicotine have been correlated with From the Department of Pharmacology, University of Michigan, 
Ann Arbor, and the Department of Neurosurgery, University of EEG effects. Two studies have reported cardiovascu- 
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METHODS 
Subjects. All procedures involving experiments on 
human subjects were done in accord with the ethical 
standards of the Helsinki Declaration of 1975. Eighty- 
five healthy adult male Japanese volunteers gave in- 
formed consent to participate. Twenty were nonsmok- 
ers (age range, 19 to 42 years; mean age t SE, 
27.0 -+ 1.9 years). Sixty-five were daily smokers (age 
range, 20 to 48 years; mean age * SE, 27.7 + 0.8 
years). The tobacco smokers had all smoked cigarettes 
and inhaled tobacco smoke for many years. All 
smoked their own brands of commercial cigarettes of 
known nicotine (0.5 to 2.7 mg; mean ? SE, 0.9 -+ 
0.05 mg) and tar (6 to 26 mg; mean -+ SE, 10 t 0.6 
mg) content. The subjects were asked to stop smoking 
about 11 PM the night before. They came to the labo- 
ratory at about 8:30 AM the next day and smoked one 
of their own cigarettes at about 9 to 10 AM after an ap- 
proximately 10 to 12-hour period of abstinence. Each 
subject was allowed to eat a small breakfast and to 
drink fluids; however, subjects were asked to not 
drink any caffeine-containing beverages. 
Scalp electrodes were applied to record monopo- 
lady 16 channels of EEG by use of the 10-20 Interna- 
tional System. Each subject lay in a bed in the EEG 
laboratory. Before sham or tobacco smoking, a 10 ml 
venous blood sample was drawn into a heparinized 
tube and labeled for nicotine and cotinine analyses. 
There was a 2-minute rest period during which the 
subject closed his eyes and attempted to relax for an- 
other 2 minutes. After all recordings were satisfac- 
tory, the subject was asked to either sham smoke a 
placebo cigarette or smoke one cigarette of his own 
brand. The nonsmokers inhaled air through the pla- 
cebo cigarette to simulate smoke inhalation. Tobacco 
smokers were asked to smoke in comfort and inhale 
deeply but at their usual rates of smoking. Filter ciga- 
rettes were permitted as long as they were the sub- 
ject's usual brand. The EEG recordings were repeated 
immediately thereafter, as were the postsmoking 
blood samples. 
EEG recordings and analysis. The experimental 
design used 16 scalp cortical recording sites from mo- 
nopolar records linking A, to the left and A, to the 
right ear as reference leads per the 10-20 International 
System. EEG recordings were taken from scalp elec- 
trodes attached with electrode paste with use of a 
Nihon Kohden 17 channel EEG, model 4317 (Nihon 
Kohden Corp., Tokyo, Japan). The EEG data were re- 
corded on paper on line and also on quarter-inch mag- 
netic tape. A Sony tape recording system (NFR-3000, 
model DRF-39515, Tokyo, Japan) was used for re- 
cording all 16 channels of EEG data. An interface was 
provided by a Magatani unit which allowed 16 chan- 
nel recording on an 8 channel Sony tape recorder. 
Subsequently, at the experimenter's convenience, the 
data were replayed from the tape recorder back 
through the EEG amplifiers into the Nihon Kohden 
ATAC power frequency spectral analyzer. Monopolar 
EEG recordings were taken from F,, , F,,, F,, F,, C,, 
C4, P3, P4, F7, F8, T5, T6, Fz9 Pr, and 0, .  The 
EEG amplifier band width was 1 to 30 Hz, with the 60 
Hz filter on. 
The topographic EEG data were analyzed on the ba- 
sis of voltages grouped in a 6 X 6 grid representing 
the top of the head. The technique used was described 
by Ueno et a1.I8 The total summated activity for all 16 
channels of EEG data was computed for each fre- 
quency band: delta, 1.0 to 3.4 Hz; theta, 3.6 to 7.4 
Hz; alpha,, 7.6 to 10 Hz; alpha,, 10.2 to 12.4 Hz; 
beta, 12.6 to 26 Hz. Dominant alpha frequency before 
and after smoking was calculated from the spectral 
analysis of Pz. Ten seconds of artifact-free typical 
records were analyzed before and immediately after 
tobacco or sham smoking. 
Nicotine analysis. Venous blood samples were re- 
moved just before and after tobacco smoking. Each 
blood sample collected in a heparinized tube was 
placed on ice for subsequent centrifugation while the 
experiment was conducted. Plasma samples were re- 
moved and stored at -70" C .  Plasma nicotine was 
subsequently measured by use of the HPLC method 
described by Hariharan et a1. l 9  This method has a sen- 
sitivity of 1 nglml nicotine and 5 nglml cotinine. 
Cardiovascular parameters. Systolic and diastolic 
blood pressures were determined from the most acces- 
sible arm by use of an automatic blood pressure mon- 
itor (Life Scope 7, model OEC-7402, Nihon Kohden 
Corp.). Blood pressure was expressed in millimeters 
of mercury. Heart rate was calculated from lead I1 of 
the electrocardiogram. Eyelid blink rates were counted 
as EMG artifacts from F,, or F,, of the EEG. Both 
heart and eye blink rates were expressed as events per 
minute. 
Carbon monoxide and carboxyhemoglobin. The 
exhaled air carbon monoxide level was measured by a 
Gastec carbon monoxide detector (Gastec Co., Kana- 
gawa, Japan). The red blood cell carboxyhemoglobin 
was measured by use of an IL 282 CO-Oxymeter (In- 
strumentation Laboratory, Lexington, Mass.). 
Data analysis. All data were analyzed by use of 
one-factor ANOVA (Scheffe's test) and linear regres- 
sion analyses, with p < 0.05 considered to be statisti- 
cally significant. 
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Table I. Change in mean total electroencephalographic activity per frequency band and the range of plasma 
nicotine concentrations 
Concentration of 
plasma nicotine Delta (KV)  Theta ( p V )  Alpha, (KV)  Alphaz (PV) Beta ( p V )  
Nonsmokers -0.64 + 0.10 -0.42 + 0.09 -0.31 2 0.13 0.87 + 0.13 0.43 + 0.05 
0.1-4.9 ngiml -0.02 2 0.09 0.42 + 0.11* 0.42 + 0.16 1.51 +- 0.13* -0.18 ? 0.09 
5.0-9.9 ngiml -0.42 ? 0.17 -0.44 +- 0.10 -0.86 + 10.20 1.12 + 0.11 0.09 + 0.10 
10.0- 14.9 ngiml -0.90 +- 0.24 -1.14 + 0.14* -4.04 2 0.28** 3.03 + 0.21** 0.36 + 0.21* 
15.0-20.5 ngiml -3.37 2 0.18** -0.60 2 0.10 -3.88 2 0.40** 0.96 2 0.23 0.84 + 0.24** 
RESULTS 
EEG effects. In view of previous litera- 
t U r e ~ . 3 , ~  1 . 1 3 . 1 5  indicating . very important alpha EEG 
changes with tobacco smoking, the EEG measure- 
ments of all 85 subjects were analyzed with respect to 
give different conditions based on the differences in 
plasma nicotine before and after smoking (Table I). A 
decrease in delta EEG activity was statistically signif- 
icant when an increase in plasma nicotine of 15 ngiml 
or more was obtained. A decrease in alpha, and an in- 
crease in beta EEG activity were statistically signifi- 
cant when an increase in plasma nicotine of 10 ngiml 
or more was obtained. Additional changes in the mean 
total EEG activity were noted with plasma nicotine 
concentrations that included theta and varying alpha, 
activity, as noted in Table I, but no clear linear rela- 
tionship over increasing nicotine concentrations was 
noted. Nonsmokers who inhaled air to mimic smoking 
had EEG changes that were not statistically signifi- 
cant. 
The relationship between the difference (A) in mean 
EEG activity of all 16 channels and plasma nicotine 
levels before and after smoking for each of 85 volun- 
teers is shown in Fig. 1, A through D. Statistically 
significant correlations were observed between the 
change in delta (p < 0.05) and alpha, (p < 0.01), but 
not mean theta and alpha, activity and plasma nicotine 
level. Linear regression analyses between the differ- 
ence in the mean EEG activity and plasma nicotine 
levels revealed the following: difference in mean delta 
activity and plasma nicotine, y = - 0 . 1 1 8 ~  + 0.049, 
in which y is the change in mean delta and x is the 
change in plasma nicotine level. The correlation coef- 
ficient was r =0.224 (p < 0.05). The difference in 
mean alpha, activity and plasma nicotine was y = 
- 0 . 2 6 9 ~  + 0.43, in which y is the change in mean 
alpha, and x is the change in plasma nicotine level. 
The correlation coefficient was r = 0.342 (p < 0.01). 
The correlation coefficient of mean theta activity and 
plasma nicotine was r = 0.126 (p > 0.1, which is not 
significant with use of a two-tailed t test). The equa- 
tion for alpha, activity and plasma nicotine was y = 
0 . 1 5 ~  + 0.752, in which y is the change in mean al- 
pha, activity and x is the change in plasma nicotine. 
The correlation coefficient was r = 0.164 (p 5 0.1, 
which is not significant with use of a two-tailed t test). 
The mean dominant alpha frequency at P, before sham 
smoking was 9.70 Hz. After sham smoking, the non- 
smokers showed no increase in their dominant alpha 
frequencies. The dominant alpha frequency before to- 
bacco smoking was 9.70 to 10.25 Hz. After tobacco 
smoking the dominant alpha frequency range was 10 
to 12 Hz. A statistically significant correlation exists 
between the increase in dominant alpha frequency and 
the increase in plasma nicotine levels (Fig. 2, A).  A 
linear regression analysis between the change in dom- 
inant alpha frequency and the change in plasma nico- 
tine level indicated that y = 0 . 0 6 2 ~  - 0.043, in 
which y is the increase in dominant alpha frequency 
and x is the change in plasma nicotine level. The cor- 
relation coefficient was r = 0.402 (p < 0.01). The 
difference in mean beta activity and plasma nicotine 
was y = 0 . 0 8 7 ~  - 0.393, in which y is the change in 
mean beta and x is the change in plasma nicotine. The 
correlation coefficient was r = 0.253 ( p  < 0.05; Fig. 
2, B). A statistically insignificant @ > 0.1) correla- 
tion was obtained between the increase in eye blink 
rate and plasma nicotine levels (r  = 0.176; Fig. 2, C) 
by use of the two-tailed Student t test. However, after 
smoking, the increase in eye blink rate and the in- 
crease in plasma nicotine (Anicotine) were signifi- 
cantly correlated (r = 0.265; p < 0.05; data not 
shown). 
Cardiovascular effects. After sham smoking, the 
nonsmokers showed no increase in mean heart rate or 
systemic arterial blood pressure. The relationship be- 
tween the difference in heart rate or blood pressure 
and nicotine levels before and after smoking for all 85 
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Fig. 1. Correlation between increase in plasma nicotine and mean total delta, theta, alpha,, and 
alpha, electroencephalographic (EEG) activity. The A increase in plasma nicotine before and after 
smoking either a sham cigarette in the case of 20 nonsmokers or a personal choice tobacco ciga- 
rette for 65 tobacco smokers is shown on the x-axis in all four graphs ( A  through D). The after 
minus before change in mean EEG activity from 16 scalp electrodes separated into delta ( A ) ,  theta 
(B), alpha, (C) ,  and alpha, ( D )  bands are plotted on the y-axis. Although there is a great deal of 
variability among individual subjects, there are statistically significant trends with respect to in- 
creasing levels of plasma nicotine except for the change in alpha, activity. Each point represents 
an individual volunteer. There are from 75 to 79 points that in some cases overlap, for a total of 
85 individual subjects. The r and p values are given in the lower right-hand comer for each 
correlation. 
volunteers is shown in Figs. 2, D and Fig. 3, A and B. 
A statistically significant positive correlation exists be- 
tween the increase in heart rate ( p  < 0.001), systolic 
blood pressure (p < 0.01), or diastolic (p < 0.001) 
blood pressure and the increase in plasma nicotine. 
Linear regression analyses of the increase in heart rate 
or blood pressure and the increase in plasma nicotine 
revealed that y = 0 . 8 2 9 ~  + 2.79, in which y is the 
increase in heart rate and x is the increase in plasma 
nicotine level. The correlation coefficient was r = 
0.588 (p < 0.001). The increase in systolic blood 
pressure and plasma nicotine level was y = 0 . 3 8 6 ~  + 
2.27, in which y is the increase in systolic blood pres- 
sure and x is the increase in plasma nicotine. The cor- 
relation coefficient was r = 0.322 (p < 0.01). The in- 
crease in diastolic blood pressure and the increase in 
plasma nicotine level was y = 0 . 3 8 6 ~  + 1.41, in 
which y is the increase in diastolic blood pressure and 
x is the increase in plasma nicotine. The correlation 
coefficient was r = 0.512 (p < 0.001). 
Exhaled carbon monoxide, carboxyhemoglobin, 
and EEG changes after tobacco smoking. Relatively 
high positive correlations were found between the in- 
crease in exhaled carbon monoxide, carboxyhemo- 
globin, and the increase in plasma nicotine (Fig. 3, C 
and D). Linear regression analysis of the increase in 
exhaled carbon monoxide or carboxyhemoglobin and 
the increase in plasma nicotine revealed that y = 
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Fig. 2. Correlation between the increase in plasma nicotine, dominant EEG alpha frequency, beta 
activity, eye blink, and heart rate. Graphs A through D in this and the subsequent figure are sim- 
ilar to those in Fig. I. There are significant correlations in mean dominant alpha and beta activity 
and in heart rate with increasing plasma nicotine levels. For the dominant alpha EEG analysis, the 
data of 51 subjects were used because of computer data recovery problems on the remaining 
subjects. 
0 . 2 5 4 ~  + 0.905, in which y is the increase in exhaled 
carbon dioxide and x is the increase in plasma nico- 
tine. The correlation coefficient was r = 0.571 @ < 
0.001). The increase in carboxyhemoglobin and the 
increase in plasma nicotine level was y = 0 . 5 9 ~  + 
0.216, in which y is the increase in carboxyhemoglo- 
bin and x is the increase in plasma nicotine level. The 
correlation coefficient was r = 0.71 1 @ < 0.001). 
The change in delta, theta, alpha,, alpha,, and beta 
EEG activity did not correlate significantly with the 
change in exhaled carbon monoxide or carboxyhemo- 
globin after tobacco smoking (p < 0.05). The changes 
in heart rate and systolic and diastolic blood pressure 
did correlate significantly with the change in exhaled 
carbon monoxide and carboxyhemoglobin (p < 
0.001). 
DISCUSSION 
To our knowledge, the mathematic relationship of 
human EEG responses to blood levels of nicotine has 
never been reported before this study. ~ n o t t '  found an 
increase in alpha activity during and after smoking. 
Norton et a1.I4 reported a decrease in alpha activity, 
whereas higher amounts of nicotine caused slower 
wave delta and theta activity than lower doses. Norton 
et a1. l 4  suggested that these differences may be related 
to dose. However, these investigators did not measure 
plasma nicotine levels before and after smoking. In 
addition, their recording of alpha activity was not di- 
vided into alpha, and alpha, sub-bands. Domino and 
M a t ~ u o k a ' ' ~ ' ~  observed that after tobacco smoking the 
topographic distribution of EEG frequencies showed a 
more diffuse increase in alpha, (10.25 to 12.5 Hz) and 
a decrease in alpha, (7.75 to 10 Hz) in most subjects 
in a dose-related fashion. Although many types of 
EEG changes after smoking were observed in the 
present study, there was an obvious decrease in alpha, 
activity after tobacco smoking in subjects that had 
mean increases in a plasma nicotine greater than 10 
ngtml. An increase in plasma nicotine levels led to 
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Fig. 3. Correlation between the increase in plasma nicotine, systolic and diastolic blood pressure, 
exhaled carbon monoxide, and carboxyhemoglobin. All four correlations are highly statistically 
significant as noted. The best positive correlation is between the increase in plasma nicotine and 
red blood cell carboxyhemoglobin (r = 0.71 I ) .  
significant decreases in delta and alpha, activity and 
an increase in beta activity in the present study. Be- 
nowitz et a1.20 reported that 10 healthy men from the 
San Francisco area who smoked their usual brands of 
cigarettes after an overnight abstinence from tobacco 
use and had a morning presmoking mean * SE 
plasma nicotine level of 2.7 5 1.7 nglml and a 
postsmoking mean increment of 14.3 nglml. A similar 
plasma increment was obtained for smokeless to- 
bacco. This finding is remarkably similar to the 10 to 
15 nglml increment obtained in the present study for 
an obvious EEG change. How wonderfully curious 
that San Francisco male tobacco users should achieve 
plasma nicotine levels that male tobacco smokers from 
Kitakyushu require for clear-cut brain wave changes. 
A 15 nglml increment in plasma nicotine seems to be 
rather high for the average Japanese male tobacco 
smoker (Domino EF, Kadoya C, Matsuoka S. Unpub- 
lished observations, June 1993). More subtle EEG 
changes occur at much lower increments of plasma 
nicotine because of the significant correlations ob- 
tained in the present study (see Table I). ~o ld ing '  re- 
ported a shift to a higher dominant alpha frequency af- 
ter tobacco smoking. The present data are similar and 
suggest that an increase of 10 nglml in plasma nico- 
tine level leads to a shift to an approximately 0.6 Hz 
higher dominant frequency. Golding and ~ a n ~ a n " . ~ ~  
reported that smoking was associated with EEG stim- 
ulation (as measured by a decrease in alpha amplitude) 
under conditions of sensory isolation and EEG seda- 
tion (as measured by an increase in alpha amplitude) 
during stress. Wesnes and ~ a r b u r t o n ~ ~  observed that 
tobacco cigarette smoking increased speed and accu- 
racy in a concentration-demanding rapid-processing 
task. The present experiments were done with the eyes 
closed and relatively low levels of arousal. The ob- 
served decreases in delta and alpha, activity, and in- 
creases in beta activity and dominant alpha frequency 
are consistent with nicotine induced cerebral stimula- 
tion. 
Inasmuch as increased arousal tends to increase the 
eye blinking rate, a positive correlation was predicted 
with increasing plasma nicotine levels. The present 
data showed a positive trend, but this was not statisti- 
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cally significant by means of a two-tailed r test. As ex- 
pected, cigarette smoking, as compared with sham 
smoking, significantly elevated heart rate, systolic 
blood pressure, and diastolic blood pressure. Hopkins 
et a1.I6 and Hasenfratz et al.17 concluded that the heart 
rate increase correlates closely with plasma nicotine. 
The data of the present study are in complete agree- 
ment. Birbaumer et failed to show any differ- 
ences in cardiovascular responses between cigarettes 
that contained different levels of nicotine. It is possi- 
ble that this may be the result of a failure to measure 
plasma nicotine, which is the critical independent 
variable. 
The observed highly significant ( p  < 0.001) posi- 
tive correlations between the increase in exhaled car- 
bon monoxide and carboxyhemoglobin and the in- 
crease in plasma nicotine levels are to be expected. 
Perhaps this explains why there were also significant 
correlations with heart rate and blood pressure when 
the variance was much less than with the EEG mea- 
sures, which were not significantly correlated with ei- 
ther exhaled carbon monoxide or carboxyhemoglobin. 
The positive correlation between the increase in the 
dominant alpha frequency and the increase in exhaled 
carbon monoxide after smoking may be expected be- 
cause the latter correlates significantly with the in- 
crease in plasma nicotine levels. Hasenfratz et al.I7 
reported that female tobacco smokers after smoking 
two cigarettes, which took about 10 minutes, could be 
separated into high and low plasma nicotine groups. 
The change in plasma nicotine was very different for 
both groups, but the change in exhaled carbon monox- 
ide was similar. In the present study, the change in 
plasma nicotine correlated positively with the change 
in exhaled carbon monoxide and carboxyhemoglobin 
shortly after smoking. If the EEG changes were pri- 
marily caused by the change in plasma nicotine (and 
therefore brain nicotine), one would expect more sig- 
nificant correlations with plasma nicotine than carbon 
monoxide or carboxyhemoglobin because the half-life 
of nicotine is much shorter than that of carbon monox- 
ide or carboxyhemoglobin. It is clear that individual 
tobacco smokers vary markedly in the way and how 
often they inhale while smoking. Even with an at- 
tempt to standardize smoking techniques, it is obvious 
that it did not succeed for the individual variability in 
all three parameters was considerable. 
The present research has several obvious weak- 
nesses. First, although each smoker stated that he had 
stopped smoking overnight for a 10- to 12-hour period 
of abstinence, some of the presmoking levels of 
plasma nicotine and the carbon monoxide levels were 
higher than those that would be expected in an absti- 
nent person. One tobacco smoker even had a higher 
prenicotine than postnicotine plasma level, suggesting 
a mislabeling of blood samples. However, none of the 
data from any subject were deleted from the present 
analysis. Second, a reference montage was used for 
16 channels of monopolar EEG recordings. Yet we 
chose to calculate mean EEG voltage difference (after 
and before) to obtain a single value for each frequency 
band as a measure of total brain electrical activity. 
Obviously, a detailed topographic analysis of the data 
needs to be done to identify discrete regional brain 
differences. This will be the subject of a future report. 
Third, the selection of the EEG segments to be ana- 
lyzed was based on discarding obvious EEG recording 
artifacts, including eye blinks, electrode wire sway, 
and motor movements, and is subject to subjective 
bias. 
Considering all of the individual variability ob- 
sewed, as well as weaknesses in the study design, it is 
remarkable that a number of variables were found to 
correlate significantly with the increase in plasma nic- 
otine levels, as would be predicted from previous lit- 
erature on tobacco smoking. 
We acknowledge Tadahiro Ishikawa, who was involved 
in the EEG studies, and Terry C. Lie, who assisted in the 
data analyses. 
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